vs

Side-by-side financial comparison of ChargePoint Holdings, Inc. (CHPT) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

ChargePoint Holdings, Inc. is the larger business by last-quarter revenue ($105.7M vs $83.1M, roughly 1.3× PROCEPT BioRobotics Corp). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -49.7%, a 11.6% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 6.1%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -4.5%).

ChargePoint Holdings, Inc. is an American electric vehicle infrastructure company based in Campbell, California. ChargePoint operates the largest online network of independently owned EV charging stations operating in 14 countries and makes some of its technology.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

CHPT vs PRCT — Head-to-Head

Bigger by revenue
CHPT
CHPT
1.3× larger
CHPT
$105.7M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+14.1% gap
PRCT
20.2%
6.1%
CHPT
Higher net margin
PRCT
PRCT
11.6% more per $
PRCT
-38.1%
-49.7%
CHPT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-4.5%
CHPT

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
CHPT
CHPT
PRCT
PRCT
Revenue
$105.7M
$83.1M
Net Profit
$-52.5M
$-31.6M
Gross Margin
30.7%
64.9%
Operating Margin
-42.0%
-4.1%
Net Margin
-49.7%
-38.1%
Revenue YoY
6.1%
20.2%
Net Profit YoY
32.4%
-27.9%
EPS (diluted)
$-2.23
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHPT
CHPT
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$105.7M
$76.4M
Q3 25
$98.6M
$83.3M
Q2 25
$97.6M
$79.2M
Q1 25
$101.9M
$69.2M
Q4 24
$99.6M
$68.2M
Q3 24
$108.5M
$58.4M
Q2 24
$107.0M
$53.4M
Net Profit
CHPT
CHPT
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-52.5M
$-29.8M
Q3 25
$-66.2M
$-21.4M
Q2 25
$-57.1M
$-19.6M
Q1 25
$-58.8M
$-24.7M
Q4 24
$-77.6M
$-18.9M
Q3 24
$-68.9M
$-21.0M
Q2 24
$-71.8M
$-25.6M
Gross Margin
CHPT
CHPT
PRCT
PRCT
Q1 26
64.9%
Q4 25
30.7%
60.6%
Q3 25
31.2%
64.8%
Q2 25
28.7%
65.4%
Q1 25
28.2%
63.9%
Q4 24
22.9%
64.0%
Q3 24
23.6%
63.2%
Q2 24
22.1%
59.0%
Operating Margin
CHPT
CHPT
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-42.0%
-40.6%
Q3 25
-59.8%
-27.8%
Q2 25
-55.1%
-28.0%
Q1 25
-53.9%
-39.7%
Q4 24
-68.4%
-28.9%
Q3 24
-57.8%
-38.4%
Q2 24
-62.7%
-50.3%
Net Margin
CHPT
CHPT
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-49.7%
-39.1%
Q3 25
-67.1%
-25.7%
Q2 25
-58.5%
-24.7%
Q1 25
-57.7%
-35.8%
Q4 24
-77.9%
-27.6%
Q3 24
-63.5%
-35.9%
Q2 24
-67.1%
-48.0%
EPS (diluted)
CHPT
CHPT
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-2.23
$-0.54
Q3 25
$-2.85
$-0.38
Q2 25
$-0.12
$-0.35
Q1 25
$-5.83
$-0.45
Q4 24
$-3.56
$-0.34
Q3 24
$-3.22
$-0.40
Q2 24
$-0.17
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHPT
CHPT
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$180.5M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$38.4M
$347.7M
Total Assets
$848.0M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHPT
CHPT
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$180.5M
$286.5M
Q3 25
$194.1M
$294.3M
Q2 25
$195.9M
$302.7M
Q1 25
$224.6M
$316.2M
Q4 24
$219.4M
$333.7M
Q3 24
$243.3M
$196.8M
Q2 24
$261.9M
$214.1M
Total Debt
CHPT
CHPT
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
CHPT
CHPT
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$38.4M
$365.9M
Q3 25
$70.7M
$380.3M
Q2 25
$118.6M
$385.8M
Q1 25
$137.5M
$389.2M
Q4 24
$181.0M
$402.2M
Q3 24
$230.9M
$241.2M
Q2 24
$277.9M
$251.8M
Total Assets
CHPT
CHPT
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$848.0M
$508.1M
Q3 25
$870.3M
$511.5M
Q2 25
$897.6M
$513.1M
Q1 25
$898.2M
$519.4M
Q4 24
$966.3M
$534.0M
Q3 24
$1.0B
$374.1M
Q2 24
$1.1B
$374.4M
Debt / Equity
CHPT
CHPT
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHPT
CHPT
PRCT
PRCT
Operating Cash FlowLast quarter
$-22.5M
Free Cash FlowOCF − Capex
$-23.6M
FCF MarginFCF / Revenue
-22.3%
Capex IntensityCapex / Revenue
1.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHPT
CHPT
PRCT
PRCT
Q1 26
Q4 25
$-22.5M
$-10.3M
Q3 25
$-6.2M
$-6.6M
Q2 25
$-33.0M
$-15.0M
Q1 25
$-2.7M
$-17.0M
Q4 24
$-30.6M
$-32.4M
Q3 24
$-51.2M
$-18.8M
Q2 24
$-62.5M
$-15.7M
Free Cash Flow
CHPT
CHPT
PRCT
PRCT
Q1 26
Q4 25
$-23.6M
$-12.2M
Q3 25
$-7.5M
$-9.5M
Q2 25
$-34.0M
$-17.8M
Q1 25
$-4.6M
$-18.8M
Q4 24
$-33.4M
$-33.6M
Q3 24
$-55.0M
$-19.0M
Q2 24
$-66.0M
$-16.8M
FCF Margin
CHPT
CHPT
PRCT
PRCT
Q1 26
Q4 25
-22.3%
-15.9%
Q3 25
-7.6%
-11.4%
Q2 25
-34.9%
-22.5%
Q1 25
-4.5%
-27.2%
Q4 24
-33.5%
-49.2%
Q3 24
-50.7%
-32.6%
Q2 24
-61.7%
-31.4%
Capex Intensity
CHPT
CHPT
PRCT
PRCT
Q1 26
Q4 25
1.0%
2.4%
Q3 25
1.3%
3.4%
Q2 25
1.1%
3.5%
Q1 25
1.9%
2.7%
Q4 24
2.8%
1.7%
Q3 24
3.5%
0.4%
Q2 24
3.2%
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHPT
CHPT

Products$56.4M53%
License And Service$42.0M40%
Other$7.3M7%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons